{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:50:28Z","timestamp":1791985828790,"version":"4.4.0"},"reference-count":33,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100013120","name":"European Medicines Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Janus kinase inhibitors (JAKi) are increasingly used for autoimmune conditions despite existing safety concerns. This study aims to estimate the incidence of new JAKi use over time and characterise users in Europe to support future safety studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included individuals from five European data sources within the DARWIN EU network: FinOMOP\u2010HILMO (Finland; primary and secondary care), IPCI (the Netherlands; primary), IQVIA DA Germany (Germany; primary), NLHR (Norway; primary and secondary), VID (Spain; primary and secondary) from 1 January 2017. Annual incidence of JAKi (abrocitinib, baricitinib, filgotinib, tofacitinib, upadacitinib) was up to 31 December 2023. Patient characteristics and treatment duration were described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Incidence of JAKi use increased over time, with transient declines during the COVID\u201019 pandemic. Initiators, except for abrocitinib, were predominantly aged 41\u201360\u2009years. Rheumatoid arthritis was the most common indicated condition, except for abrocitinib, for which atopic dermatitis predominated. Median treatment duration was generally less than 1\u2009year. Tofacitinib and baricitinib had the lowest proportions of prior JAKi use, whereas up to 17% and 16% of upadacitinib and filgotinib initiators had received prior treatment with another JAKi. Findings were consistent across data sources, although incidence rates varied according to the healthcare sector captured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Incidence of JAKi use generally increased, with tofacitinib being the most initiated JAKi. Treatment durations were relatively short and switching between JAKi was common. The current study provides an overview of indication distribution and characterises JAKi treatment, while offering a framework for future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pds.70502","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:19:35Z","timestamp":1791983975000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal Trends in Janus Kinase Inhibitor (\n                    <scp>JAKi<\/scp>\n                    ) Use Across Five European Countries: A\n                    <scp>DARWIN EU<\/scp>\n                    Network Study"],"prefix":"10.1002","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8112-8959","authenticated-orcid":false,"given":"Xihang","family":"Chen","sequence":"first","affiliation":[{"name":"Pharmaco\u2010 and Device Epidemiology Group, Health Data Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8978-1525","authenticated-orcid":false,"given":"Andrei","family":"Barbulescu","sequence":"additional","affiliation":[{"name":"Data Analytics and Methods Task Force Real World Evidence Department European Medicines Agency  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-2985","authenticated-orcid":false,"given":"George","family":"Corby","sequence":"additional","affiliation":[{"name":"Pharmaco\u2010 and Device Epidemiology Group, Health Data Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Hayati","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy University of Oslo  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-0110","authenticated-orcid":false,"given":"Annika","family":"Jodicke","sequence":"additional","affiliation":[{"name":"Pharmaco\u2010 and Device Epidemiology Group, Health Data Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2089-2299","authenticated-orcid":false,"given":"Toni","family":"Lehtonen","sequence":"additional","affiliation":[{"name":"Unit of Data Production and Methods. Data and Analytics Finnish Institute for Health and Welfare  Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6361-2918","authenticated-orcid":false,"given":"Hedvig Marie Egeland","family":"Nordeng","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy University of Oslo  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-0540","authenticated-orcid":false,"given":"Alexandra","family":"Pacurariu","sequence":"additional","affiliation":[{"name":"Data Analytics and Methods Task Force Real World Evidence Department European Medicines Agency  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-4576","authenticated-orcid":false,"given":"Gabriel","family":"Sanf\u00e9lix\u2010Gimeno","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3 Per al Foment de la Investigaci\u00f3 Sanit\u00e0ria i Biom\u00e8dica de la Comunitat Valenciana  Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2794-5322","authenticated-orcid":false,"given":"Nhung T. H.","family":"Trinh","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy University of Oslo  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8162-4904","authenticated-orcid":false,"given":"Katia","family":"Verhamme","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center  Rotterdam CA the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-0232","authenticated-orcid":false,"given":"Dina","family":"Vojinovic","sequence":"additional","affiliation":[{"name":"IQVIA  Amsterdam CT the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-6346","authenticated-orcid":false,"given":"Daniel","family":"Prieto\u2010Alhambra","sequence":"additional","affiliation":[{"name":"Pharmaco\u2010 and Device Epidemiology Group, Health Data Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0139-2328","authenticated-orcid":false,"given":"Amy Shuk\u2010Man","family":"Lam","sequence":"additional","affiliation":[{"name":"Pharmaco\u2010 and Device Epidemiology Group, Health Data Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9286-1128","authenticated-orcid":false,"given":"Edward","family":"Burn","sequence":"additional","affiliation":[{"name":"Pharmaco\u2010 and Device Epidemiology Group, Health Data Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.01.032"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.2146\/news120088"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.3516"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15514"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665\u20109913(21)00010\u20102"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4090"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocu023"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70042"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5717"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654\u2010025\u201001352\u20104"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5809"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584\u2010023\u201001062\u20109"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744\u2010021\u201000357\u20101"},{"key":"e_1_2_13_16_1","volume-title":"Assessment Report\u2014Janus Kinase Inhibitors (JAKi) Article 20 Procedure","author":"Pharmacovigilance Risk Assessment Committee (PRAC)","year":"2021"},{"key":"e_1_2_13_17_1","volume-title":"EMA Confirms Measures to Minimise Risk of Serious Side Effects With Janus Kinase Inhibitors for Chronic Inflammatory Disorders","author":"EMA","year":"2023"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16030465"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16655"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2023.4578"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2103726"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.010"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast\u20102024\u2010001347"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/n0kjax"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010021\u201004075\u20100"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard\u20102022\u2010222405"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard\u20102022\u2010222543"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen\u20102024\u2010004987"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.70199"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403\u2010025\u201004035\u2010y"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000809"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard\u20102022\u2010222835"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac285"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.07.001"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70502","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pds.70502","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:19:37Z","timestamp":1791983977000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.70502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1002\/pds.70502"],"URL":"https:\/\/doi.org\/10.1002\/pds.70502","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"2026-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70502"}}